In Treatment and prevention of Chronic obstructive pulmonary disease (COPD) Vibdoxo M 400mg/10mg Tablet can help prevent the onset of an asthma attack if it is taken before exercise or exposure to some “triggers”. These may include house dust, pollen, pets, and cigarette smoke. This medicine will allow you to exercise more freely without worrying about getting symptoms such as wheezing, coughing, and shortness of breath. It allows you to live your life more freely without worrying so much about things that set off your symptoms.
Caution is advised when consuming alcohol with Vibdoxo M 400mg/10mg Tablet. Please consult your doctor.
Information regarding the use of Vibdoxo M 400mg/10mg Tablet during pregnancy is not available. Please consult your doctor.
Vibdoxo M 400mg/10mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Vibdoxo M 400mg/10mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
There is limited information available on the use of Vibdoxo M 400mg/10mg Tablet in patients with kidney disease. Please consult your doctor.
Vibdoxo M 400mg/10mg Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Vibdoxo M 400mg/10mg Tablet may be needed. Please consult your doctor. Limited information is available on the use of Vibdoxo M 400mg/10mg Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
If you miss a dose of Vibdoxo M 400mg/10mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Daemon Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ventus Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Getron Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Acekinetics Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Koye Pharmaceuticals Pvt ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Elkos Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Vistica Life Sciences || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ridhima Biocare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Intra Life || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Phoenix Biotech || ₹14.5/tablet (25% cheaper)